DENALI THERAPEUTICS

Lobbying client · California · filed 2025 to 2026

Biopharmaceutical Company

$415,000 Reported spend

7 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 7 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (65725), not by name.

Firms hired 1

MANATT, PHELPS, AND PHILLIPS $415,000 7 filings

Reported by year 2 years

2026 $140,000 2 filings
2025 $275,000 5 filings

Issues lobbied 1

Health Issues 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Recent filings 8 total

Q2Y

MANATT, PHELPS, AND PHILLIPS

2nd Quarter (Apr 1 - June 30) 2026 · $70,000 income · posted Jul 14, 2026

View → Q1

MANATT, PHELPS, AND PHILLIPS

1st Quarter (Jan 1 - Mar 31) 2026 · $70,000 income · posted Apr 6, 2026

View → Q4

MANATT, PHELPS, AND PHILLIPS

4th Quarter (Oct 1 - Dec 31) 2025 · $70,000 income · posted Jan 13, 2026

View → Q3

MANATT, PHELPS, AND PHILLIPS

3rd Quarter (July 1 - Sep 30) 2025 · $70,000 income · posted Oct 15, 2025

View → Q2

MANATT, PHELPS, AND PHILLIPS

2nd Quarter (Apr 1 - June 30) 2025 · $67,500 income · posted Jul 10, 2025

View → 1A

MANATT, PHELPS, AND PHILLIPS

1st Quarter (Jan 1 - Mar 31) 2025 · $67,500 income · posted Apr 15, 2025

View → Q1

MANATT, PHELPS, AND PHILLIPS Amended

1st Quarter (Jan 1 - Mar 31) 2025 · $67,500 income · posted Apr 15, 2025

View → RR

MANATT, PHELPS, AND PHILLIPS

1st Quarter (Jan 1 - Mar 31) 2025 · posted Apr 14, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.